Intech Biopharm Corporation

Intech Biopharm Corporation

6461.TWO
Intech Biopharm CorporationTW flagTaipei Exchange
15.70
TWD
-0.05
- -
2.38BMarket Cap

Intech Biopharm Corporation (6461.TWO) Stock Split History

Learn about Intech Biopharm Corporation's most recent 513-for-500 basis stock split on September 26, 2023. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Intech Biopharm Corporation's most recent stock split

Split Date: 2023-09-26
Split Ratio: 513:500
Price Before Split: $29.45
Price After Split: $28.70

Developer API

Get 6461.TWO split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/6461.TWO

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.03 times more shares (a 513:500 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Intech Biopharm Corporation's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2023-09-26513:500No$29.45$28.70
2019-10-28507:500No$20.45$20.17

About Intech Biopharm Corporation

Company overview and industry information

Intech Biopharm Corporation (6461.TWO) operates in the Biotechnology industry. The recent 513-for-500 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Biotechnology
Go to Intech Biopharm Corporation Summary

Last updated: 7/6/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.